Birnbaum v. Birrell
Opinion
In these stockholders’ derivative actions, the surviving plaintiffs and the defendant Universal Laboratories, Inc. have brought on for hearing, by order to show cause, motions to dismiss the actions subject to court approval of settlements, pursuant to Rule 23(c), Federal Rules of Civil Procedure, 28 U.S.C.A. The ex parte order to show cause provided for the publication of a notice in the New York Times and in the New York Law Journal, the notice to appear twice in each publication not less than ten days 1: efore the hearing date specified. On the return date of the motion there appeared in opposition holders of 100 shares of common stock,
Footnotes
17 F.R.D. 409 (Birnbaum v. Birrell) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.